4 Top Growth Stocks Worth Buying Under $100 Today
Yahoo Finance ·
Not every great investment story comes from a household name. Sometimes the best opportunities are found in overlooked industrial and healthcare companies quietly benefiting from long-term trends that could drive years of steady growth. Let's look at three of them today. Enovis ( ENOV +12.28% ) makes orthopedic reconstruction implants and surgical instruments. This is the hardware that goes into shoulder, hip, and knee replacement procedures. That is a market with a long, demographic-driven runway: An aging U.S. population that is more active and less willing to live with joint pain than any prior generation. What Enovis is doing right now is building its reconstructive segment at a pace that the Prevention & Recovery side of the business doesn't fully reflect in the stock price. Reconstructive sales grew 11% in Q1 2026 while full-year guidance for 4% to 6% organic growth was reaffirmed. The company completed the acquisition of LimaCorporate in 2024, adding a complementary hip and knee portfolio that broadens its geographic reach in Europe. Eleven analysts cover Enovis with a Strong Buy consensus and an average price target of $42 -- roughly 91% above today's $22.
DYAX Investor Sentiment
Bullish (Long) 39% · Bearish (Short) 61%
299 participants
Related News
- Microsoft Launches AI Adoption Firm
- Meta Is Reportedly Building a Cloud Business to Rival Amazon and Microsoft -- and a Way to Make Its Massive AI Bet Pay Off
- JPMorgan Loses Javice Legal Fee Fight
- These Investors Say Buy Meta Platforms (META) and Ignore SpaceX Hype
- Sandisk Stock Is Up More Than 6,000% Since Spinning Off From Western Digital. Is a Stock Split on the Horizon?
- 1 Industrials Stock to Own for Decades and 2 We Question